Cinemark price target raised to $30 from $29 at B. Riley

B. Riley analyst Drew Crum raised the firm’s price target on Cinemark (CNK) to $30 from $29 and keeps a Neutral rating on the shares. Cinemark reported Q4 results roughly in line with reduced expectations, with revenue down 5% year over year and AEBITDA down 16%, while average ticket price and concession per capita rose 9% and 11%, respectively, the analyst tells investors in a research note. Management expressed optimism for CY26 box office trends, the firm adds.